|
2026-10-15 |
2026-10-15 |
PrS
Proposed sale
|
Officer
Officer
|
82,865
175.60
US$4,977,581
|
82,865
|
175.60
|
US$4,977,581
|
|
|
2026-09-17 |
2026-09-15 |
S
Sale
|
President, Global Head of R&D
Officer
|
17,105
-45.9%
479.59
US$492,140
|
17,105
-45.9%
|
479.59
|
US$492,140
|
|
|
2026-09-17 |
2026-09-15 |
S
Sale
|
President, Global Head of R&D
Officer
|
75,405
+1.2%
411.11
US$326,891
|
75,405
+1.2%
|
411.11
|
US$326,891
|
|
|
2026-09-17 |
2026-09-15 |
S
Sale
|
President, Global Head of R&D
Officer
|
9,233
-4.5%
120.50
US$1,112,576
|
9,233
-4.5%
|
120.50
|
US$1,112,576
|
|
|
2026-09-17 |
2026-09-15 |
S
Sale
|
President, Global Head of R&D
Officer
|
9,233
-4.5%
120.50
US$1,112,576
|
9,233
-4.5%
|
120.50
|
US$1,112,576
|
|
|
2026-09-15 |
2026-09-15 |
PrS
Proposed sale
|
Officer
Officer
|
23,218
120.49
US$2,797,571
|
23,218
|
120.49
|
US$2,797,571
|
|
|
2026-08-20 |
2026-08-19 |
S
Sale
|
President, Global Head of R&D
Officer
|
10,801
-5.6%
125.56
US$1,356,174
|
10,801
-5.6%
|
125.56
|
US$1,356,174
|
|
|
2026-08-19 |
2026-08-19 |
PrS
Proposed sale
|
Officer
Officer
|
10,801
125.56
US$1,356,190
|
10,801
|
125.56
|
US$1,356,190
|
|
|
2026-08-14 |
2026-08-12 |
S
Sale
|
President, Global Head of R&D
Officer
|
10,803
-5.3%
120.04
US$1,296,792
|
10,803
-5.3%
|
120.04
|
US$1,296,792
|
|
|
2026-08-12 |
2026-08-12 |
PrS
Proposed sale
|
Officer
Officer
|
10,803
120.04
US$1,296,774
|
10,803
|
120.04
|
US$1,296,774
|
|
|
2026-08-07 |
2026-08-05 |
S
Sale
|
President, Global Head of R&D
Officer
|
10,640
-4.9%
122.69
US$1,305,422
|
10,640
-4.9%
|
122.69
|
US$1,305,422
|
|
|
2026-08-07 |
2026-08-05 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
2,207
-3.5%
123.99
US$273,646
|
2,207
-3.5%
|
123.99
|
US$273,646
|
|
|
2026-08-05 |
2026-08-05 |
PrS
Proposed sale
|
Officer
Officer
|
10,640
122.69
US$1,305,450
|
10,640
|
122.69
|
US$1,305,450
|
|
|
2026-08-05 |
2026-08-05 |
PrS
Proposed sale
|
Officer
Officer
|
2,207
123.99
US$273,646
|
2,207
|
123.99
|
US$273,646
|
|
|
2026-08-04 |
2026-08-03 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
6,055
-9.0%
120.43
US$729,204
|
6,055
-9.0%
|
120.43
|
US$729,204
|
|
|
2026-08-03 |
2026-08-03 |
PrS
Proposed sale
|
Officer
Officer
|
6,055
120.43
US$729,204
|
6,055
|
120.43
|
US$729,204
|
|
|
2026-08-04 |
2026-07-31 |
S
Sale
|
President, Global Head of R&D
Officer
|
15,888
-6.9%
119.70
US$1,901,794
|
15,888
-6.9%
|
119.70
|
US$1,901,794
|
|
|
2026-08-04 |
2026-07-31 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
2,293
-3.6%
119.41
US$273,807
|
2,293
-3.6%
|
119.41
|
US$273,807
|
|
|
2026-08-04 |
2026-07-31 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
326
-0.5%
121.69
US$39,671
|
326
-0.5%
|
121.69
|
US$39,671
|
|
|
2026-08-04 |
2026-07-31 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
85
-0.1%
122.19
US$10,386
|
85
-0.1%
|
122.19
|
US$10,386
|
|
|
2026-08-04 |
2026-07-31 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
1,642
-2.5%
119.38
US$196,022
|
1,642
-2.5%
|
119.38
|
US$196,022
|
|
|
2026-08-04 |
2026-07-31 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
1,643
-2.4%
119.51
US$196,355
|
1,643
-2.4%
|
119.51
|
US$196,355
|
|
|
2026-08-04 |
2026-07-31 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
2,864
-4.1%
119.40
US$341,962
|
2,864
-4.1%
|
119.40
|
US$341,962
|
|
|
2026-08-04 |
2026-07-31 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
4,695
-6.3%
119.39
US$560,536
|
4,695
-6.3%
|
119.39
|
US$560,536
|
|
|
2026-08-04 |
2026-07-31 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
6,171
-7.6%
119.43
US$737,003
|
6,171
-7.6%
|
119.43
|
US$737,003
|
|
|
2026-08-04 |
2026-07-31 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
2,187
-2.6%
119.47
US$261,281
|
2,187
-2.6%
|
119.47
|
US$261,281
|
|
|
2026-08-04 |
2026-07-31 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
5,332
-6.0%
119.42
US$636,747
|
5,332
-6.0%
|
119.42
|
US$636,747
|
|
|
2026-08-04 |
2026-07-31 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
14,661
-14.2%
119.46
US$1,751,403
|
14,661
-14.2%
|
119.46
|
US$1,751,403
|
|
|
2026-07-31 |
2026-07-31 |
PrS
Proposed sale
|
Officer
Officer
|
41,899
119.46
US$5,005,186
|
41,899
|
119.46
|
US$5,005,186
|
|
|
2026-07-31 |
2026-07-31 |
PrS
Proposed sale
|
Officer
Officer
|
15,888
119.70
US$1,901,833
|
15,888
|
119.70
|
US$1,901,833
|
|
|
2026-07-20 |
2026-07-16 |
S
Sale
|
CMO & Head of Late-Stage Dev.
Officer
|
1,877
-8.2%
114.73
US$215,348
|
1,877
-8.2%
|
114.73
|
US$215,348
|
|
|
2026-07-20 |
2026-07-16 |
S
Sale
|
EVP, Head of U.S. Commercial
Officer
|
1,093
-1.7%
115.01
US$125,706
|
1,093
-1.7%
|
115.01
|
US$125,706
|
|
|
2026-07-16 |
2026-07-16 |
PrS
Proposed sale
|
Officer
Officer
|
1,877
114.73
US$215,339
|
1,877
|
114.73
|
US$215,339
|
|
|
2026-07-16 |
2026-07-16 |
PrS
Proposed sale
|
Officer
Officer
|
1,093
115.01
US$125,706
|
1,093
|
115.01
|
US$125,706
|
|
|
2026-07-16 |
2026-07-15 |
S
Sale
|
CMO & Head of Late-Stage Dev.
Officer
|
28,237
-52.0%
113.05
US$3,192,193
|
28,237
-52.0%
|
113.05
|
US$3,192,193
|
|
|
2026-07-15 |
2026-07-15 |
PrS
Proposed sale
|
Officer
Officer
|
28,237
113.05
US$3,192,255
|
28,237
|
113.05
|
US$3,192,255
|
|
|
2026-06-08 |
2026-06-04 |
S
Sale
|
Principal Accounting Officer
Officer
|
2,639
-11.1%
100.00
US$263,900
|
2,639
-11.1%
|
100.00
|
US$263,900
|
|
|
2026-06-08 |
2026-06-04 |
S
Sale
|
Principal Accounting Officer
Officer
|
2,639
-11.1%
100.00
US$263,900
|
2,639
-11.1%
|
100.00
|
US$263,900
|
|
|
2026-06-04 |
2026-06-04 |
PrS
Proposed sale
|
Officer
Officer
|
2,639
100.00
US$263,900
|
2,639
|
100.00
|
US$263,900
|
|
|
2026-05-28 |
2026-05-26 |
S
Sale
|
Principal Accounting Officer
Officer
|
2,051
-8.8%
97.35
US$199,665
|
2,051
-8.8%
|
97.35
|
US$199,665
|
|
|
2026-05-26 |
2026-05-26 |
PrS
Proposed sale
|
Officer
Officer
|
2,051
97.35
US$199,665
|
2,051
|
97.35
|
US$199,665
|
|
|
2026-05-21 |
2026-05-19 |
S
Sale
|
Non-Executive Director
|
15,000
-38.7%
94.93
US$1,423,950
|
15,000
-38.7%
|
94.93
|
US$1,423,950
|
|
|
2026-05-21 |
2026-05-19 |
S
Sale
|
Non-Executive Director
|
15,000
-38.7%
94.93
US$1,423,950
|
15,000
-38.7%
|
94.93
|
US$1,423,950
|
|
|
2026-05-19 |
2026-05-19 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
15,000
94.93
US$1,424,006
|
15,000
|
94.93
|
US$1,424,006
|
|
|
2026-04-21 |
2026-04-17 |
S
Sale
|
President, Global Head of R&D
Officer
|
18,667
-6.6%
96.50
US$1,801,366
|
18,667
-6.6%
|
96.50
|
US$1,801,366
|
|
|
2026-04-17 |
2026-04-17 |
PrS
Proposed sale
|
Officer
Officer
|
18,667
96.50
US$1,801,326
|
18,667
|
96.50
|
US$1,801,326
|
|
|
2026-03-19 |
2026-03-17 |
S
Sale
|
President, R&D
Officer
|
18,667
-7.4%
94.24
US$1,759,178
|
18,667
-7.4%
|
94.24
|
US$1,759,178
|
|
|
2026-03-17 |
2026-03-17 |
PrS
Proposed sale
|
Officer
Officer
|
18,667
94.24
US$1,759,102
|
18,667
|
94.24
|
US$1,759,102
|
|
|
2026-02-23 |
2026-02-19 |
S
Sale
|
President, R&D
Officer
|
18,668
-7.4%
100.91
US$1,883,788
|
18,668
-7.4%
|
100.91
|
US$1,883,788
|
|
|
2026-02-19 |
2026-02-19 |
PrS
Proposed sale
|
Officer
Officer
|
18,668
100.91
US$1,883,797
|
18,668
|
100.91
|
US$1,883,797
|
|
|
2026-02-09 |
2026-02-09 |
PrS
Proposed sale
|
Officer
Officer
|
12,743
109.00
US$1,388,987
|
12,743
|
109.00
|
US$1,388,987
|
|
|
2026-01-08 |
2026-01-07 |
S
Sale
|
EVP, Head of US Oncology
Officer
|
10,856
-14.1%
109.07
US$1,184,064
|
10,856
-14.1%
|
109.07
|
US$1,184,064
|
|
|
2026-01-07 |
2026-01-07 |
PrS
Proposed sale
|
Officer
Officer
|
10,856
109.07
US$1,184,051
|
10,856
|
109.07
|
US$1,184,051
|
|
|
2026-01-06 |
2026-01-06 |
PrS
Proposed sale
|
Officer
Officer
|
95,811
104.35
US$9,998,256
|
95,811
|
104.35
|
US$9,998,256
|
|
|
2026-01-07 |
2026-01-05 |
S
Sale
|
EVP & Chief Medical Officer
Officer
|
15,634
-31.4%
101.70
US$1,589,978
|
15,634
-31.4%
|
101.70
|
US$1,589,978
|
|
|
2026-01-05 |
2026-01-05 |
PrS
Proposed sale
|
Officer
Officer
|
16,437
102.81
US$1,689,888
|
16,437
|
102.81
|
US$1,689,888
|
|
|
2026-01-05 |
2026-01-05 |
PrS
Proposed sale
|
Officer
Officer
|
15,634
101.70
US$1,589,995
|
15,634
|
101.70
|
US$1,589,995
|
|
|
2025-12-22 |
2025-12-19 |
S
Sale
|
Principal Accounting Officer
Officer
|
2,774
-10.8%
100.00
US$277,400
|
2,774
-10.8%
|
100.00
|
US$277,400
|
|
|
2025-12-19 |
2025-12-19 |
PrS
Proposed sale
|
Officer
Officer
|
2,774
100.00
US$277,400
|
2,774
|
100.00
|
US$277,400
|
|
|
2025-12-19 |
2025-12-19 |
PrS
Proposed sale
|
Officer
Officer
|
52,941
101.73
US$5,385,677
|
52,941
|
101.73
|
US$5,385,677
|
|
|
2025-12-22 |
2025-12-18 |
S
Sale
|
Principal Accounting Officer
Officer
|
600
-2.5%
98.25
US$58,950
|
600
-2.5%
|
98.25
|
US$58,950
|
|
|
2025-12-18 |
2025-12-18 |
PrS
Proposed sale
|
Officer
Officer
|
600
98.25
US$58,950
|
600
|
98.25
|
US$58,950
|
|
|
2025-12-18 |
2025-12-17 |
S
Sale
|
EVP, Head of Tech. Operations
Officer
|
4,323
-13.6%
97.26
US$420,455
|
4,323
-13.6%
|
97.26
|
US$420,455
|
|
|
2025-12-17 |
2025-12-17 |
PrS
Proposed sale
|
Officer
Officer
|
4,323
97.26
US$420,455
|
4,323
|
97.26
|
US$420,455
|
|
|
2025-12-18 |
2025-12-16 |
S
Sale
|
EVP, Head of Tech. Operations
Officer
|
53,175
-62.6%
97.29
US$5,173,396
|
53,175
-62.6%
|
97.29
|
US$5,173,396
|
|
|
2025-12-18 |
2025-12-16 |
S
Sale
|
EVP, Head of Tech. Operations
Officer
|
833
-1.0%
97.42
US$81,151
|
833
-1.0%
|
97.42
|
US$81,151
|
|
|
2025-12-16 |
2025-12-16 |
PrS
Proposed sale
|
Officer
Officer
|
13,388
98.39
US$1,317,245
|
13,388
|
98.39
|
US$1,317,245
|
|
|
2025-12-16 |
2025-12-16 |
PrS
Proposed sale
|
Officer
Officer
|
54,008
97.29
US$5,254,458
|
54,008
|
97.29
|
US$5,254,458
|
|
|
2025-12-15 |
2025-12-15 |
PrS
Proposed sale
|
Officer
Officer
|
187,690
97.00
US$18,205,930
|
187,690
|
97.00
|
US$18,205,930
|
|
|
2025-12-12 |
2025-12-11 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
255
-0.4%
94.94
US$24,210
|
255
-0.4%
|
94.94
|
US$24,210
|
|
|
2025-12-11 |
2025-12-11 |
PrS
Proposed sale
|
Officer
Officer
|
255
94.94
US$24,210
|
255
|
94.94
|
US$24,210
|
|
|
2025-12-12 |
2025-12-10 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
5,553
-8.4%
95.58
US$530,756
|
5,553
-8.4%
|
95.58
|
US$530,756
|
|
|
2025-12-10 |
2025-12-10 |
PrS
Proposed sale
|
Officer
Officer
|
5,553
95.58
US$530,756
|
5,553
|
95.58
|
US$530,756
|
|
|
2025-12-10 |
2025-12-10 |
PrS
Proposed sale
|
Officer
Officer
|
23,104
95.51
US$2,206,695
|
23,104
|
95.51
|
US$2,206,695
|
|
|
2025-12-03 |
2025-12-02 |
S
Sale
|
EVP & Chief Medical Officer
Officer
|
20,105
-24.2%
102.51
US$2,060,964
|
20,105
-24.2%
|
102.51
|
US$2,060,964
|
|